Based on the data, the forecasted sales of modulators of the genital system and sex hormones in Italy show a declining trend from 2024 onwards. Sales are expected to decline from $97.9 million in 2024 to $85.7 million by 2028. The year-on-year variations indicate a consistent decrease, reflecting challenges in this market segment.
From 2024 to 2028, the market exhibits the following average trends:
- 2025: -3.88%
- 2026: -3.40%
- 2027: -3.08%
- 2028: -2.73%
These yearly declines contribute to a compound annual growth rate (CAGR) of approximately -3.23% over the 5-year period.
Looking ahead, key trends to monitor include advancements in biotechnology and personalized medicine that may drive future innovation and potentially alter the sales trajectory. Additionally, regulatory changes and shifts in healthcare policies in Italy could impact demand dynamics in this market.
